SOLIGENIX, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SOLIGENIX, INC. stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $5.00K.
- SOLIGENIX, INC. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $10.00K, a 66.66% decline year-over-year.
- SOLIGENIX, INC. stock issued during period, value, issued for services for the quarter ending 2025-12-31 was $0.00.
- SOLIGENIX, INC. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $46.60K.
- SOLIGENIX, INC. stock issued during period, value, issued for services for fiscal 2025 was $76.60K, a 384.81% increase from fiscal 2024.
- SOLIGENIX, INC. stock issued during period, value, issued for services for fiscal 2024 was $15.80K, a 78.36% decline from fiscal 2023.
- SOLIGENIX, INC. stock issued during period, value, issued for services for fiscal 2023 was $73.00K, a 65.57% decline from fiscal 2022.
- SOLIGENIX, INC. stock issued during period, value, issued for services for fiscal 2022 was $212.00K, a 670.92% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | $5.00K 10-Q · filed 2026-08-07 | $61.60K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $10.00K 10-Q · filed 2026-05-08 | $56.60K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $76.60K 10-K · filed 2026-03-31 |
| 2025-09-30 | $46.60K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | |
| 2025-03-31 | $30.00K 10-Q · filed 2026-05-08 | |
| 2024-12-31 | $15.80K 10-K · filed 2026-03-31 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $73.00K 10-K · filed 2025-03-21 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | |
| 2023-06-30 | $73.00K 10-Q · filed 2024-08-09 | |
| 2022-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $212.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | $50.00K 10-Q · filed 2023-11-13 | $150.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $50.00K 10-Q · filed 2023-08-21 | $127.50K derived: sum of 4 quarters · filed 2023-08-21 |
| 2022-03-31 | $50.00K 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $27.50K 10-K · filed 2023-03-31 |
| 2021-09-30 | $27.50K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $59.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $59.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $103.68K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $59.00K 10-Q · filed 2021-05-18 | $207.14K derived: sum of 4 quarters · filed 2021-05-18 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $205.74K 10-K · filed 2021-03-30 |
| 2019-09-30 | $44.68K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $103.46K 10-Q · filed 2020-08-14 | |
| 2019-03-31 | $57.60K 10-Q · filed 2020-05-15 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $5.92K 10-K · filed 2019-03-26 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $5.92K derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $21.93K derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-03-31 | $5.92K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $52.50K 10-K · filed 2018-03-15 |
| 2016-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | |
| 2015-12-31 | $41.95K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $232.21K 10-K · filed 2017-03-27 |
| 2015-09-30 | $71.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $190.26K derived: sum of 4 quarters · filed 2016-03-24 |
| 2015-06-30 | $17.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $221.26K derived: sum of 4 quarters · filed 2016-03-24 |
| 2015-03-31 | $101.36K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | $256.04K 10-K · filed 2016-03-24 |
| 2014-09-30 | $102.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | |
| 2013-12-31 | $22.56K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | $82.15K 10-K · filed 2015-03-25 |
| 2013-09-30 | $23.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $65.59K derived: sum of 4 quarters · filed 2014-03-26 |
| 2013-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $53.89K derived: sum of 4 quarters · filed 2014-03-26 |
| 2013-03-31 | $32.89K 10-Q · filed 2013-05-03 | $53.89K derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $21.00K 10-K · filed 2014-03-26 |
| 2012-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | |
| 2012-06-30 | $3.00K 10-Q · filed 2012-08-10 | |
| 2011-12-31 | $15.00K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |